Indies Pharma Jamaica Limited (JMSE:INDIES)

Indies Pharma Jamaica Revenue

Indies Pharma Jamaica had revenue of 260.04M JMD in the quarter ending July 31, 2025, a decrease of -12.29%. This brings the company's revenue in the last twelve months to 1.15B, up 1.04% year-over-year. In the fiscal year ending October 31, 2024, Indies Pharma Jamaica had annual revenue of 1.16B with 9.81% growth.

• Revenue (ttm): 1.15B
• Revenue Growth: +1.04%
• P/S Ratio: 3.47
• Revenue / Employee: 17.66M
• Employees: 65
• Market Cap: 3.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2024	1.16B	103.52M	9.81%
Oct 31, 2023	1.06B	118.18M	12.61%
Oct 31, 2022	937.28M	90.45M	10.68%
Oct 31, 2021	846.83M	80.88M	10.56%
Oct 31, 2020	765.95M	36.50M	5.00%